These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3609099)

  • 1. Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer.
    Norlén BJ; Fritjofsson A; Grönquist L; Gunnarsson PO; Johansson SA; Plym-Forshell G
    Eur Urol; 1987; 13(3):193-7. PubMed ID: 3609099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients.
    Stege R; Gunnarsson PO; Johansson CJ; Olsson P; Pousette A; Carlström K
    Prostate; 1996 May; 28(5):307-10. PubMed ID: 8610057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single drug polyestradiol phosphate therapy in prostatic cancer.
    Stege R; Carlström K; Collste L; Eriksson A; Henriksson P; Pousette A
    Am J Clin Oncol; 1988; 11 Suppl 2():S101-3. PubMed ID: 3242384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of orchiectomy and polyestradiol phosphate therapy on serum lipoprotein lipids and glucose tolerance in prostatic cancer patients.
    Aro J; Haapiainen R; Sane T; Rannikko S; Pelkonen R; Alfthan O
    Eur Urol; 1990; 17(3):229-35. PubMed ID: 2351192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of polyestradiol phosphate.
    Gunnarsson PO; Norlén BJ
    Prostate; 1988; 13(4):299-304. PubMed ID: 3217277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-drug parenteral estrogen treatment in prostatic cancer: a study of two maintenance-dose regimens.
    Stege R; Carlström K; Collste L; Eriksson A; Henriksson P; Pousette A; von Schoultz B
    Prostate; 1989; 14(2):183-8. PubMed ID: 2710692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer.
    Johansson CJ; Gunnarsson PO
    Prostate; 2000 Jun; 44(1):26-30. PubMed ID: 10861754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
    Carlström K; Stege R
    Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen.
    Henriksson P; Carlström K; Pousette A; Gunnarsson PO; Johansson CJ; Eriksson B; Altersgård-Brorsson AK; Nordle O; Stege R
    Prostate; 1999 Jul; 40(2):76-82. PubMed ID: 10386467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma.
    Carlström K; Stege R; Henriksson P; Grande M; Gunnarsson PO; Pousette A
    Prostate; 1997 May; 31(3):193-7. PubMed ID: 9167772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.
    Leinonen P; Hammond GL; Lukkarinen O; Vihko R
    Invest Urol; 1979 Jul; 17(1):24-7. PubMed ID: 571863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment hormone levels in prostatic cancer.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study.
    Hedlund PO; Henriksson P
    Urology; 2000 Mar; 55(3):328-33. PubMed ID: 10699602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancer.
    Hagenfeldt Y; Carlström K; Berlin T; Stege R
    J Steroid Biochem Mol Biol; 1991 Aug; 39(2):155-9. PubMed ID: 1888674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
    Lukkarinen O; Hammond GL; Kontturi M; Vihko R
    Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
    Berglund L; Carlström K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2633-7. PubMed ID: 8675589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
    Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
    J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
    Aro J
    Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
    Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
    Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen dosage in prostatic cancer: the threshold effect?
    Bishop MC; Lemberger RJ; Selby C; Lawrence WT
    Br J Urol; 1989 Sep; 64(3):290-6. PubMed ID: 2679960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.